TrialJournal of experimental & clinical cancer research : CR2023

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.

Kerstin Wimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.